DALLAS - s4story -- A Cure In Sight (ACIS), in collaboration with UT Southwestern Medical Center, brought patients, caregivers, physicians, researchers, and advocates together for the 2026 Eye Believe Survivorship Seminar in Dallas. Held October 2–3, the event combined ocular melanoma education with practical support and opportunities to connect with others navigating the disease.

Hosted with J. William "Bill" Harbour, MD, Professor and Chair of Ophthalmology at UT Southwestern, and Sanjay Chandrasekaran, MD, of UT Southwestern's Division of Hematology and Oncology, Eye Believe offered in-person and virtual participation for patients and caregivers from diagnosis through survivorship and metastatic disease.

A highlight of the weekend was a tour of the Harbour Lab, where attendees met the scientists studying ocular melanoma.

More on S For Story

• Claude Zdanow named Managing Director in Miami, Florida
• Birch Tree Publishing Launches as Independent Publishing Imprint
• Pharmacist Flo Launches New Children's Book, "Pharmacist Flo's Halloween Adventure"
• Pregis Launches Sharp InfinX: On-Demand Rightsized Mailing System Delivering a Precision-Sized Mailer for Every Order
• New Book Release - The Legend in the Stone

"This was an amazing experience for all of us. The scientists were equally overjoyed to see and chat with us. It was like putting the puzzle all together," said H. McMenamin.

Attendees also joined a HEPZATO tour and educational demonstration led by Dr. Chandrasekaran and Adrienne Shannon, MD, connecting discussions of liver-directed treatment for metastatic uveal melanoma with the clinical setting.

The medical program covered surveillance testing, biomarkers, adjuvant therapy, treatment sequencing, liver-directed therapies, emerging immunotherapy and targeted therapies, and symptom management after eye treatment. Patient and caregiver sessions addressed mental health, caregiver support, insurance, advocacy, and financial assistance, alongside patient roundtables and an INSIGHT Registry workshop.

"Eye Believe brings patients and caregivers into the conversation with the physicians and researchers working to improve their care," said Melody Burchett, Founder and President of A Cure In Sight. "The Harbour Lab tour and HEPZATO demonstration made those connections especially meaningful. We are grateful to UT Southwestern, our speakers, and our sponsors for helping us create a place where families can learn, ask questions, and find support."

More on S For Story

• netElastic Announces vBNG And CGNAT 2.0 General Availability
• Shadow of a Survivor: This Astonishing Memoir - From One of the World's Longest Cancer Survivors
• Award-Winning Author Robert L. Cauley Relaunches Hit Sci-Fi Series Under New Imprint
• Adapters By Felipe Veit Helps Professionals Turn Experience Into an Advantage in the Age of AI
• Joel Rodriguez Tirado Releases Grandpa's Toolbox: The Tools You Need to Build a Great Life

Featured speakers represented UT Southwestern Medical Center, Bascom Palmer Eye Institute, Princess Margaret Cancer Centre, Memorial Sloan Kettering Cancer Center, Sylvester Comprehensive Cancer Center, Northwestern University's Lurie Cancer Center, Keck School of Medicine of USC, Triage Cancer, Natera, and Oncobit, along with patient speaker Sophie Cantu and mental health professionals.

The 2026 Eye Believe Survivorship Seminar was supported by presenting sponsor Castle Biosciences, along with sponsors Immunocore, Delcath Systems, Aura Biosciences, IDEAYA Biosciences, TrilliumBio, and Novelwise.

Looking ahead, the 2027 Eye Believe Survivorship Seminar will be held with Dr. Carvajal and Dr. Materin at Northwell in Manhattan, New York. Additional details will be announced by A Cure In Sight. https://acureinsight.org/